Open AccessInterleukin-2: A Potential Treatment Option for Postherpetic Neuralgia?
Author(s) -
J. Rotty,
L. M. Heinzerling,
Dirk Schürmann,
Norbert Suttorp
Publication year - 2006
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/509639
Subject(s) - postherpetic neuralgia , medicine , chronic pain , neuralgia , dermatology , surgery , anesthesia , neuropathic pain , physical therapy
Postherpetic neuralgia is a chronic pain syndrome that is often difficult to treat and can lead to a disabling disease if it is resistant to therapy. Presented here is the case of a 46-year-old patient with human immunodeficiency virus infection and chronic, treatment-resistant neuralgia. Postherpetic pain resolved after treatment with 1 cycle of subcutaneous recombinant interleukin-2.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom